Nightingale, developed by Medical Marijuana Genetics, is a hybrid between Shiskaberry and their Candida with 10-20% CBD content.
There are basically two phenotypes of Nightingale: one closer to Candida, more Sativa and with 1:1 THC:CBD ratio, and another one more Indica which, according to the studies conducted by MMG, can reach 1:20 THC:CBD ratio, up to 20% cannabidiol.
The flowering period lasts around 8-9 weeks, while yields are between 300 and 500g/m2 of frosty buds.
According to MMG, this strain is suitable to treat chronic pain, nausea, vomiting, insomnia and also multiple sclerosis.
Medical Marijuana Genetics Nightingale info:
Genetics: Shiskaberry x Candida
Type: Feminized seeds
Mostly Indica hybrid
Indoor flowering: 8-99 weeks
Yield: 300-500g/m2
THC content: from 0,68 to 9%
CBD content: from 10,3% to 20,3%
THC:CBD ratio: from 1:1 to 1:20